Drug Regulatory Authority of Pakistan

The Drug Regulatory Authority of Pakistan (DRAP) is a self-governing entity under the Federal Government of Pakistan. It functions under the administrative supervision of the Ministry of National Health Services, Regulations & Coordination. DRAP was formed in accordance with the DRAP Act 2012 and is tasked with ensuring effective coordination and implementation of The Drugs Act, 1976.[1][2]

Drug Regulatory Authority of Pakistan (DRAP)
AbbreviationDRAP
Formation2012
TypeAutonomous body
Legal statusActive
HeadquartersIslamabad, Pakistan
Region served
Pakistan
CEO
Asim Rauf
Parent organization
Ministry of National Health Services, Regulations & Coordination
Websitewww.dra.gov.pk

Role and responsibilities

DRAP is committed to ensuring that all drugs, medical devices, cosmetics, alternative medicines, and health products meet a certain standard of quality and are safe and effective for use.[3] It is responsible for making sure that therapeutic goods, which are approved and available in the market, comply with the prescribed standards of quality, safety, and efficacy. The regulatory tasks carried out by DRAP encompass registration and marketing authorization, vigilance, market surveillance and control, licensing establishments, regulatory inspection, laboratory testing, clinical trials oversight, pharmacovigilance, and lot release of biologicals.[4]

Initiatives

Response to the shortage of medicines

In response to the shortage of life-saving medicines across the country, DRAP has taken several initiatives:

DRAP has set the maximum retail prices for 25 life-saving drugs and 25 newly introduced medicines in an effort to make these essential drugs more affordable for the public.[5][6]

A committee was formed to propose strategies to alleviate the scarcity of life-saving medicines and liaise with pharmaceutical manufacturers and importers.[7]

DRAP App

In an effort to eradicate black market practices and put an end to hoarding, DRAP introduced a mobile application. This app provides real-time and evidence-based information about drug shortages in the market.[4]

Importing Indian drugs

There is no restriction on hospitals or individuals on importing vital medicines from India for their own use under the Import Policy Order 2022 after obtaining a No Objection Certificate (NOC) from DRAP.[3]

Crackdown on spurious medicines

DRAP decided to launch a crackdown against spurious medicines to eradicate the menace of unregistered, spurious and sub-standard medicine.[8]

Controversies

Allegations have been made against Asim Rauf the CEO of DRAP for operating a Benami pharmaceutical company, which is perceived as a clear instance of conflict of interest.[9]

References
  1. https://na.gov.pk/uploads/documents/1352964021_588.pdf
  2. Ullah, Asad (October 11, 2022). "DRAP Act 2012".
  3. "No restriction on importing Indian drugs in Pakistan: DRAP". www.geo.tv.
  4. "Aug 27, 2023 | Drap App to target hoarders, end drugs paucity". Dawn Epaper. August 27, 2023.
  5. "Pakistan's drug regulatory authority fixes maximum retail price for 25 life-saving medicines". Arab News PK. August 24, 2023.
  6. Desk, Web (August 23, 2023). "DRAP sets prices for 25 newly introduced medicines". ARY NEWS.
  7. "Committee formed to address shortage of life-saving medicines". The Express Tribune. September 3, 2023.
  8. Khan, Jahangir (September 26, 2023). "DRAP to launch 'crackdown' against spurious medicines". ARY NEWS.
  9. "Jun 19, 2023 | Drap chief accused of running Benami pharmaceutical company". Dawn Epaper. June 19, 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.